Sustained activation of AMP‐activated protein kinase induces c‐Jun N‐terminal kinase activation and apoptosis in liver cells

D. Meisse(de Duve Institute), Mark Van de Casteele(Center for Beta Cell Therapy in Diabetes), Christophe Beauloye(de Duve Institute), Isabelle Hainault(Inserm), Benjamin Kefas(Center for Beta Cell Therapy in Diabetes), Mark H. Rider(de Duve Institute), Fabienne Foufelle(Inserm), Louis Hue(de Duve Institute)
FEBS Letters
July 25, 2002
Cited by 204

Abstract

The aim of this work was to study the effect of a sustained activation of AMP-activated protein kinase (AMPK) on liver cell survival. AMPK activation was achieved by incubating FTO2B cells with AICA-riboside, which is transformed into ZMP, an AMP analogue, or by adenoviral transfection of hepatocytes with a constitutively active form of AMPK. Prolonged AMPK activation triggered apoptosis and activated c-Jun N-terminal kinase (JNK) and caspase-3. Experiments with iodotubercidin, dicoumarol and z-VAD-fmk, which inhibited AMPK, JNK and caspase activation, respectively, supported the notion that prolonged AMPK activation in liver cells induces apoptosis through an activation pathway that involves JNK and caspase-3.


Related Papers

No related papers found

Powered by citation graph analysis